For the Inventor, By the Inventor

Enter assignee name

Middlesex, United Kingdom

Glaxosmithkline Intellectual Property (no.2) Limited

USPTO Granted Patents = 92

Trademarks = 6

Forward Citations = 192

Loading Chart...

Loading Chart...

192 inventors (with patents filed for the assignee):

Stephen John Atkinson (15 out of 23 patents)

Alexander G Preston (15 out of 16 patents)

Jonathan Thomas Seal (15 out of 23 patents)

4. Lee Andrew Harrison (14 out of 22 patents)

5. Emmanuel Hubert Demont (11 out of 23 patents)

6. Ian David Wall (11 out of 13 patents)

7. Robert J Watson (11 out of 17 patents)

8. James Michael Woolven (10 out of 11 patents)

9. Matthew John Lindon (9 out of 13 patents)

10. Myrna A Monck (8 out of 9 patents)

11. Narendra B Bam (8 out of 11 patents)

12. Jennifer Dally (8 out of 9 patents)

13. Michelle Spatara (8 out of 9 patents)

14. Mui Cheung (7 out of 43 patents)

15. Carl A Brooks (6 out of 10 patents)

Core Competencies:

Biopharmaceutical Compositions

Bromodomain Inhibitors

Antibody Purification

TRPV4 Antagonists

Crystalline Forms

Pediatric Patients

HIV Therapy

Chemical Compounds

Nicotinamide Riboside

Intravenous Administration

Dosing Regimen

Combination Therapies

92 patents: Sort by Forward Citations

1. 12358945 - Methods for purifying antibodies (2025-07-15),

2. 12286472 - Biopharmaceutical compositions and methods for pediatric patients (2025-04-29),

3. 12240853 - Compounds useful in HIV therapy (2025-03-04),

4. 12187791 - Biopharmaceutical compositions (2025-01-07),

5. 12187790 - Biopharmaceutical compositions (2025-01-07),

6. 12187789 - Biopharmaceutical compositions (2025-01-07),

7. 12060431 - Dosing regimen of combination of ANTICD20 and anti-BlyS antibodies (2024-08-13),

8. 11649217 - Crystalline forms of GSK1278863, preparation method and pharmaceutical use thereof (2023-05-16),

9. 11478478 - 2,3-disubstituted 1-acyl-4-amino-1,2,3,4-tetrahydroquinoline derivatives and their use as bromodomain inhibitors (2022-10-25),

10. 11459384 - Biopharmaceutical compositions (2022-10-04),

11. 11319307 - 2,3-dihydrobenzohurans as bromodomain inhibitors (2022-05-03),

12. 11299541 - Biopharmaceutical compositions (2022-04-12),

13. 11299457 - Chemical compounds (2022-04-12),

14. 11286298 - Biopharmaceutical compositions (2022-03-29),

15. 11274148 - Biopharmaceutical compositions (2022-03-15),

GlaxoSmithKline Intellectual Property (No.2) Limited is a subsidiary of GlaxoSmithKline, a leading global healthcare company. They focus on the development, manufacturing, and marketing of pharmaceuticals, vaccines, and consumer healthcare products. With a wide range of innovative medicines and healthcare solutions, GSK aims to improve the quality of human life and contribute to the healthcare industry.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

92 Patents

#5 in Middlesex

#191 in United Kingdom

#8,086 in the World

Middlesex, United Kingdom

Glaxosmithkline Intellectual Property (no.2) Limited

Forward Citations = 192

192 inventors:

Stephen John Atkinson (15 out of 23 patents)

Alexander G Preston (15 out of 16 patents)

Jonathan Thomas Seal (15 out of 23 patents)

4. Lee Andrew Harrison (14 out of 22 patents)

5. Emmanuel Hubert Demont (11 out of 23 patents)

Please report any incorrect information to support@idiyas.com

Loading…